Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG

Erlagen, DE

FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG Patent applications
Patent application numberTitlePublished
20110143394Methods and Means for Metabolic Engineering and Improved Product Formation by Micro-Organisms - The invention relates to the field of biochemistry, molecular biology and microbiology. More specific the invention relates to methods and means for metabolic engineering and improved product formation by a filamentous micro-organism or a low G+C gram-positive bacterium.06-16-2011
20110081549AIN BULK SINGLE CRYSTAL, SEMICONDUCTOR DEVICE USING THE SAME AND METHOD FOR PRODUCING THE SAME - An object of the present invention is to provide, even when a single crystal of a material other than AlN is used as a crystal, an AlN bulk single crystal having fewer defects and high quality, a method for producing such an AlN bulk single crystal, and a semiconductor device. A feature is to select, as a surface 04-07-2011
20110051901METHOD AND APPARATUS FOR DETERMINING ONE OR MORE CHARACTERISTICS OF RADIATION - The present invention relates to a device and method for determining one or more characteristics of radiation using a sensor comprising one or more detector units capable of counting the number of photon or charged particle of said radiation impinging on said sensor in or above a determined energy range.03-03-2011
20090239311Method of Differentially Diagnosing Dementias - In an ex vivo method of differentially diagnosing dementias selected from a group of demetias, which includes vascular dementias and frontotemporal lobe degenerations, a concentration of at least one carboxy-terminally truncated amyloid β peptide species as a biomarker is determined in a body fluid obtained from a patient, the at least one carboxy-terminally truncated amyloid β peptide species being selected from the group of species consisting of Aβ1-38, Aβ1-37 and Aβ1-39; and the concentration of the at least one carboxy-terminally truncated amyloid β peptide species is compared to a threshold concentration value for the respective one carboxy-terminally truncated amyloid β peptide species.09-24-2009

Patent applications by FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG